[What is assured in therapy with expectorants?]. 1989

J Schlegel, and R Ferlinz
III. Medizinische Klinik, Schwerpunkt Pneumologie der Universität Mainz.

UI MeSH Term Description Entries
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D011663 Pulmonary Surfactants Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI. Surfactants, Pulmonary,Pulmonary Surfactant,Surfactant, Pulmonary
D005100 Expectorants Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. Expectorant,Mucolytic,Mucolytic Agent,Mucolytic Agents,Mucolytics,Agent, Mucolytic,Agents, Mucolytic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Schlegel, and R Ferlinz
December 1993, Der Internist,
J Schlegel, and R Ferlinz
December 1993, Der Internist,
J Schlegel, and R Ferlinz
December 1989, Der Internist,
J Schlegel, and R Ferlinz
December 1993, Der Internist,
J Schlegel, and R Ferlinz
December 1993, Der Internist,
J Schlegel, and R Ferlinz
July 1973, Medizinische Klinik,
J Schlegel, and R Ferlinz
May 1980, MMW, Munchener medizinische Wochenschrift,
J Schlegel, and R Ferlinz
December 1972, Der Internist,
Copied contents to your clipboard!